PMID,QID,Question,Human Answer,gpt5-mini,human_norm,gpt5_norm
18715920,7,From what years were the sequenced samples obtained?,No,Not reported; the paper provides selection durations in days/passages but does not specify calendar years for sample collection.,no,not reported passages but does not specify calendar years for sample collection the paper provides selection durations in days
18715920,9,Which HIV genes were reported to have been sequenced?,IN,The integrase (IN) coding region of pol was sequenced (IN was the target); cDNA for reverse transcriptase and IN was generated but genotyping focused on the IN region.,in,cdna for reverse transcriptase in was generated but genotyping focused on the in region the integrase in coding region of pol was sequenced in was the target
18715920,10,What method was used for sequencing?,Sanger sequencing,Automated population-based Sanger sequencing (ABI Prism BigDye Terminator cycle sequencing) of PCR products.,sanger sequencing,automated population based sanger sequencing abi prism bigdye terminator cycle sequencing of pcr products
18715920,11,What type of samples were sequenced?,No,Viral RNA extracted from culture supernatant or virus stock (in vitro–selected virus populations and regrown virus stocks) were sequenced.,no,regrown virus stocks were sequenced viral rna extracted from culture supernatant virus stock in vitro selected virus populations
19104010,5,How many individuals had samples obtained for HIV sequencing?,0,Zero patient individuals; sequencing was performed on viral material from cell culture passages and cloned PCR products.,no,cloned pcr products sequencing was performed on viral material from cell culture passages zero patient individuals
19104010,8,Were samples cloned prior to sequencing?,No,Yes.,no,yes
19104010,9,Which HIV genes were reported to have been sequenced?,IN,Integrase (IN) gene; PCR fragment spanned from RT through Vpr but sequencing focused on IN.,in,integrase in gene pcr fragment spanned from rt through vpr but sequencing focused on in
19104010,10,What method was used for sequencing?,No,Cycle sequencing with the BigDye terminator v3.1 kit and analysis on an ABI Prism 3100 genetic analyzer (Sanger sequencing chemistry).,no,analysis on an abi prism 3100 genetic analyzer sanger sequencing chemistry cycle sequencing with the bigdye terminator v3 1 kit
19104010,11,What type of samples were sequenced?,No,"Viral DNA extracted from infected cell culture passages, amplified by PCR and cloned into plasmid clones (plasmid-derived inserts were sequenced).",no,amplified by pcr cloned into plasmid clones plasmid derived inserts were sequenced viral dna extracted from infected cell culture passages
21115794,5,How many individuals had samples obtained for HIV sequencing?,0,Zero (no patient-derived samples were sequenced).,no,zero no patient derived samples were sequenced
21115794,9,Which HIV genes were reported to have been sequenced?,IN,The integrase coding region (integrase).,in,the integrase coding region integrase
21115794,10,What method was used for sequencing?,No,Sequencing of PCR products was performed by Operon Biotechnologies' sequencing service.,no,sequencing of pcr products was performed by operon biotechnologies sequencing service
21115794,11,What type of samples were sequenced?,No,Proviral DNA from infected cell cultures (DNA extracted from infected cells following in vitro passage).,no,proviral dna from infected cell cultures dna extracted from infected cells following in vitro passage
23749954,2,Does the paper report in vitro drug susceptibility data?,No,Yes — the paper reports in vitro cell culture drug selection experiments assessing resistance mutation selection under drug pressure.,no,yes
23749954,9,Which HIV genes were reported to have been sequenced?,RT,"The study focused on the reverse transcriptase (RT) region (codons around positions 64/65, 70, 210, 219 and the K65R mutation).",rt,210 219 65 70 the k65r mutation the study focused on the reverse transcriptase rt region codons around positions 64
24227862,8,Were samples cloned prior to sequencing?,No,Yes — site-directed cloning was performed to generate recombinant NL4.3 clones prior to sequencing for verification.,no,yes
24227862,9,Which HIV genes were reported to have been sequenced?,RT,The reverse transcriptase (RT) coding sequences were sequenced/genotyped.,rt,genotyped the reverse transcriptase rt coding sequences were sequenced
24227862,10,What method was used for sequencing?,No,DNA sequencing (method not specified).,no,dna sequencing method not specified
24227862,11,What type of samples were sequenced?,No,Laboratory-derived recombinant HIV-1 NL4.3 proviral clones and viruses harvested from cell culture (in vitro selections); genotyping was performed on virus-containing culture media.,no,genotyping was performed on virus containing culture media laboratory derived recombinant hiv 1 nl4 3 proviral clones viruses harvested from cell culture in vitro selections
25637519,8,Were samples cloned prior to sequencing?,No,Yes — plasmid clones (constructs) were generated and positive clones were identified and sequenced.,no,yes
25637519,9,Which HIV genes were reported to have been sequenced?,RT,The reverse transcriptase (RT) gene/region (including the connection subdomain) was sequenced/analysed.,rt,analysed region including the connection subdomain was sequenced the reverse transcriptase rt gene
25637519,10,What method was used for sequencing?,No,The paper states DNA sequencing was used to confirm plasmid mutations; no specific sequencing platform or method is specified.,no,method is specified no specific sequencing platform the paper states dna sequencing was used to confirm plasmid mutations
25637519,11,What type of samples were sequenced?,No,"Plasmid DNA from constructed infectious clones/mutant plasmids was sequenced (i.e., plasmid clones), not clinical patient specimens in this study.",no,mutant plasmids was sequenced i e not clinical patient specimens in this study plasmid clones plasmid dna from constructed infectious clones
26246578,5,How many individuals had samples obtained for HIV sequencing?,0,Zero — no individuals were sampled for sequencing.,no,zero no individuals were sampled for sequencing
26246578,9,Which HIV genes were reported to have been sequenced?,IN,None — no sequencing was reported; the study focused on the integrase (IN) gene via engineered mutations.,in,no
26311878,5,How many individuals had samples obtained for HIV sequencing?,0,Zero; no individual/patient samples were sequenced in this study.,no,no individual patient samples were sequenced in this study zero
26311878,6,From which countries were the sequenced samples obtained?,No,Not applicable; sequenced material was laboratory-derived (plasmids and tissue-culture viruses).,no,not applicable sequenced material was laboratory derived plasmids tissue culture viruses
26311878,8,Were samples cloned prior to sequencing?,No,Yes. Plasmids bearing the integrase mutations were generated (cloned) by site-directed mutagenesis and verified by sequencing; replication-competent genetically homogeneous viruses were produced from these plasmids.,no,yes
26311878,9,Which HIV genes were reported to have been sequenced?,No,Integrase (IN).,no,integrase in
26311878,10,What method was used for sequencing?,No,"Viral RNA was extracted and amplified by RT-PCR, and the PCR products were sequenced; plasmids were also verified by sequencing. The specific sequencing technology (e.g., Sanger or NGS) is not specified.",no,amplified by rt pcr ngs is not specified plasmids were also verified by sequencing the specific sequencing technology e g sanger the pcr products were sequenced viral rna was extracted
26311878,11,What type of samples were sequenced?,No,Sequencing was performed on PCR products derived from viral RNA extracted from tissue-culture supernatants and on plasmid DNA used to generate engineered viruses.,no,on plasmid dna used to generate engineered viruses sequencing was performed on pcr products derived from viral rna extracted from tissue culture supernatants
26311878,15,Which drug classes were received by individuals in the study before sample sequencing?,No,"Not applicable—no individuals were sampled in this study. The study used integrase strand transfer inhibitors (INSTIs: RAL, EVG, DTG) in experiments.",no,dtg in experiments elvitegravir not applicable no individuals were sampled in this study the study used integrase strand transfer inhibitors instis ral
26311878,16,Which drugs were received by individuals in the study before sample sequencing?,No,"None. No individuals in the study received drugs prior to sequencing. Experimentally, the study used the drugs raltegravir (RAL), elvitegravir (EVG), and dolutegravir (DTG) in vitro.",no,dolutegravir dtg in vitro elvitegravir evg none no individuals in the study received drugs prior to sequencing experimentally the study used the drugs raltegravir ral
26559830,5,How many individuals had samples obtained for HIV sequencing?,0,Zero; no patient samples or individuals were sequenced.,no,individuals were sequenced no patient samples zero
26559830,8,Were samples cloned prior to sequencing?,No,Yes — sequencing was performed on engineered full-length molecular clones.,no,yes
26559830,9,Which HIV genes were reported to have been sequenced?,No,The full-length viral genome was sequenced; protease (within gag-pol) was specifically manipulated and analyzed.,no,analyzed protease within gag pol was specifically manipulated the full length viral genome was sequenced
26559830,10,What method was used for sequencing?,No,The paper states that clones were sequenced but does not specify the sequencing method.,no,the paper states that clones were sequenced but does not specify the sequencing method
26559830,11,What type of samples were sequenced?,No,Full-length plasmid molecular clones (engineered infectious HIV-1 and HIV-2 clones).,no,full length plasmid molecular clones engineered infectious hiv 1 hiv 2 clones
27009474,5,How many individuals had samples obtained for HIV sequencing?,1,One individual (a single patient).,1,one individual a single patient
27009474,6,From which countries were the sequenced samples obtained?,No,Not specified in the paper.,no,not specified in the paper
27009474,7,From what years were the sequenced samples obtained?,No,2014 (patient sample) and 2015 (clones created/characterized).,no,2014 patient sample 2015 clones created characterized
27009474,9,Which HIV genes were reported to have been sequenced?,IN,Integrase was sequenced and reported; reverse transcriptase and protease regions were also genotyped (mutations reported).,in,integrase was sequenced protease regions were also genotyped mutations reported reported reverse transcriptase
27009474,10,What method was used for sequencing?,No,The specific sequencing method is not specified in the paper.,no,the specific sequencing method is not specified in the paper
27009474,11,What type of samples were sequenced?,No,Plasma-derived samples (patient's plasma sample) were used.,no,plasma derived samples patient s plasma sample were used
27009474,14,Does the paper report HIV sequences from individuals who had previously received ARV drugs?,Yes,The primary sequence in this study was from a treatment-naive individual with transmitted resistance; the paper also references GenBank sequences from raltegravir-experienced individuals.,yes,the paper also references genbank sequences from raltegravir experienced individuals the primary sequence in this study was from a treatment naive individual with transmitted resistance
27009474,15,Which drug classes were received by individuals in the study before sample sequencing?,"NRTI, INSTI",The reported patient was treated with an INSTI-containing regimen and NRTIs (tenofovir and emtricitabine); cobicistat was included as a pharmacoenhancer.,insti nrti,cobicistat was included as a pharmacoenhancer emtricitabine nrtis tenofovir the reported patient was treated with an insti containing regimen
27009474,16,Which drugs were received by individuals in the study before sample sequencing?,"Tenofovir, Emtricitabine, Elvitegravir","Tenofovir, emtricitabine, elvitegravir, and cobicistat.",elvitegravir emtricitabine tenofovir,cobicistat elvitegravir emtricitabine tenofovir
27124362,9,Which HIV genes were reported to have been sequenced?,No,The paper reports mutations and analyses of the HIV-1 reverse transcriptase (RT) gene.,no,analyses of the hiv 1 reverse transcriptase rt gene the paper reports mutations
28559249,1,Does the paper report HIV sequences from patient samples?,Yes,No.,yes,no
28559249,5,How many individuals had samples obtained for HIV sequencing?,1,The paper reports isolates from 10 HIV-1 and 14 HIV-2 strains (24 isolates total) derived from individuals.,1,14 hiv 2 strains 24 isolates total derived from individuals the paper reports isolates from 10 hiv 1
